drugset
drugset / Trial / NCT01453374

A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration

NCT01453374 ↗

Phase 4 Completed 27 enrolled Alkermes, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This phase 4 study will evaluate the feasibility of initiating subjects on VIVITROL in prison and continuing VIVITROL upon release into the community.

Timeline

Start
2011-01
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 380 mg Intramuscular

Indications

opiate dependence